Industry Research Reports

Home > Reports > Medical Devices & Consumables > CRM197 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

CRM197 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-01-05

Pages: 92 Pages

Report ld: 5509303

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

CRM197 Industry Research：the global market size is projected to reach USD 0.25 billion by 2029

CRM197 Market Size(US$)

CAGR 2026-2032

5.3%

Market Size,2032

USD 277

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 203 million

Market Forecast in 2032(Value)

US$ 277 million

CAGR

5.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for CRM197 was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 277 million, growing at a CAGR of 5.3% from 2026 to 2032.

CRM197 is a non-toxic mutant of diphtheria toxin and it"s widely used as a carrier protein for conjugate vaccines.

Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.

This report provides a comprehensive view of the global market for CRM197, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The CRM197 market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding CRM197.

MARKET SEGMENTATION

By Company

Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Research Grade CRM197
cGMP Grade CRM197

Segment by Application

Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the CRM197 companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents CRM197 revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents CRM197 revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 CRM197 Product Introduction

1.2 Global CRM197 Market Size Forecast (2021–2032)

1.3 CRM197 Market Trends & Drivers

1.3.1 CRM197 Industry Trends

1.3.2 CRM197 Market Drivers & Opportunities

1.3.3 CRM197 Market Challenges

1.3.4 CRM197 Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global CRM197 Players Revenue Ranking (2025)

2.2 Global CRM197 Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies CRM197 Product Offerings

2.5 Key Companies General Availability (GA) Timeline for CRM197

2.6 CRM197 Market Competitive Analysis

2.6.1 CRM197 Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by CRM197 Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRM197 revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation CRM197 Market Classification

3.1 Introduction by Type

3.1.1 Research Grade CRM197

3.1.2 cGMP Grade CRM197

3.1.3 Global CRM197 Sales Value by Type

3.1.3.1 Global CRM197 Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global CRM197 Sales Value, by Type (2021–2032)

3.1.3.3 Global CRM197 Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pneumococcal Conjugate Vaccine

4.1.2 Meningococcal Polysaccharide Conjugate Vaccine

4.1.3 Others

4.2 Global CRM197 Sales Value by Application

4.2.1 Global CRM197 Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global CRM197 Sales Value by Application (2021–2032)

4.2.3 Global CRM197 Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global CRM197 Sales Value by Region

5.1.1 Global CRM197 Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global CRM197 Sales Value by Region (2021–2026)

5.1.3 Global CRM197 Sales Value by Region (2027–2032)

5.1.4 Global CRM197 Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America CRM197 Sales Value, 2021–2032

5.2.2 North America CRM197 Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe CRM197 Sales Value, 2021–2032

5.3.2 Europe CRM197 Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific CRM197 Sales Value, 2021–2032

5.4.2 Asia Pacific CRM197 Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America CRM197 Sales Value, 2021–2032

5.5.2 South America CRM197 Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa CRM197 Sales Value, 2021–2032

5.6.2 Middle East & Africa CRM197 Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions CRM197 Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions CRM197 Sales Value, 2021–2032

6.3 United States

6.3.1 United States CRM197 Sales Value, 2021–2032

6.3.2 United States CRM197 Sales Value by Type (%), 2025 vs 2032

6.3.3 United States CRM197 Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe CRM197 Sales Value, 2021–2032

6.4.2 Europe CRM197 Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe CRM197 Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China CRM197 Sales Value, 2021–2032

6.5.2 China CRM197 Sales Value by Type (%), 2025 vs 2032

6.5.3 China CRM197 Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan CRM197 Sales Value, 2021–2032

6.6.2 Japan CRM197 Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan CRM197 Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea CRM197 Sales Value, 2021–2032

6.7.2 South Korea CRM197 Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea CRM197 Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia CRM197 Sales Value, 2021–2032

6.8.2 Southeast Asia CRM197 Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia CRM197 Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India CRM197 Sales Value, 2021–2032

6.9.2 India CRM197 Sales Value by Type (%), 2025 vs 2032

6.9.3 India CRM197 Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Pfizer Inc.

7.1.1 Pfizer Inc. Profile

7.1.2 Pfizer Inc. Main Business

7.1.3 Pfizer Inc. CRM197 Products, Services, and Solutions

7.1.4 Pfizer Inc. CRM197 Revenue (US$ Million), 2021–2026

7.1.5 Pfizer Inc. Recent Developments

7.2 Ligand Pharmaceuticals

7.2.1 Ligand Pharmaceuticals Profile

7.2.2 Ligand Pharmaceuticals Main Business

7.2.3 Ligand Pharmaceuticals CRM197 Products, Services, and Solutions

7.2.4 Ligand Pharmaceuticals CRM197 Revenue (US$ Million), 2021–2026

7.2.5 Ligand Pharmaceuticals Recent Developments

7.3 CanSino Biologic

7.3.1 CanSino Biologic Profile

7.3.2 CanSino Biologic Main Business

7.3.3 CanSino Biologic CRM197 Products, Services, and Solutions

7.3.4 CanSino Biologic CRM197 Revenue (US$ Million), 2021–2026

7.3.5 CanSino Biologic Recent Developments

7.4 Beijing Kexing Biology Product

7.4.1 Beijing Kexing Biology Product Profile

7.4.2 Beijing Kexing Biology Product Main Business

7.4.3 Beijing Kexing Biology Product CRM197 Products, Services, and Solutions

7.4.4 Beijing Kexing Biology Product CRM197 Revenue (US$ Million), 2021–2026

7.4.5 Beijing Kexing Biology Product Recent Developments

7.5 Scarab Genomics

7.5.1 Scarab Genomics Profile

7.5.2 Scarab Genomics Main Business

7.5.3 Scarab Genomics CRM197 Products, Services, and Solutions

7.5.4 Scarab Genomics CRM197 Revenue (US$ Million), 2021–2026

7.5.5 Scarab Genomics Recent Developments

7.6 Xpress Biologics

7.6.1 Xpress Biologics Profile

7.6.2 Xpress Biologics Main Business

7.6.3 Xpress Biologics CRM197 Products, Services, and Solutions

7.6.4 Xpress Biologics CRM197 Revenue (US$ Million), 2021–2026

7.6.5 Xpress Biologics Recent Developments

7.7 Fina Biosolutions

7.7.1 Fina Biosolutions Profile

7.7.2 Fina Biosolutions Main Business

7.7.3 Fina Biosolutions CRM197 Products, Services, and Solutions

7.7.4 Fina Biosolutions CRM197 Revenue (US$ Million), 2021–2026

7.7.5 Fina Biosolutions Recent Developments

7.8 Eubiologics

7.8.1 Eubiologics Profile

7.8.2 Eubiologics Main Business

7.8.3 Eubiologics CRM197 Products, Services, and Solutions

7.8.4 Eubiologics CRM197 Revenue (US$ Million), 2021–2026

7.8.5 Eubiologics Recent Developments

7.9 EirGenix Inc.

7.9.1 EirGenix Inc. Profile

7.9.2 EirGenix Inc. Main Business

7.9.3 EirGenix Inc. CRM197 Products, Services, and Solutions

7.9.4 EirGenix Inc. CRM197 Revenue (US$ Million), 2021–2026

7.9.5 EirGenix Inc. Recent Developments

8 Industry Chain Analysis

8.1 CRM197 Value Chain

8.2 CRM197 Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 CRM197 Sales Model

8.5.2 Sales Channels

8.5.3 CRM197 Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. CRM197 Market Trends

Table 2. CRM197 Market Drivers & Opportunities

Table 3. CRM197 Market Challenges

Table 4. CRM197 Market Restraints

Table 5. Global CRM197 Revenue by Company (US$ Million), 2021–2026

Table 6. Global CRM197 Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies CRM197 Product Type

Table 9. Key Companies General Availability (GA) Timeline for CRM197

Table 10. Global CRM197 Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on CRM197 revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global CRM197 Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global CRM197 Sales Value by Type (US$ Million), 2021–2026

Table 15. Global CRM197 Sales Value by Type (US$ Million), 2027–2032

Table 16. Global CRM197 Sales Market Share in Value by Type (2021–2026)

Table 17. Global CRM197 Sales Market Share in Value by Type (2027–2032)

Table 18. Global CRM197 Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global CRM197 Sales Value by Application (US$ Million), 2021–2026

Table 20. Global CRM197 Sales Value by Application (US$ Million), 2027–2032

Table 21. Global CRM197 Sales Market Share in Value by Application (2021–2026)

Table 22. Global CRM197 Sales Market Share in Value by Application (2027–2032)

Table 23. Global CRM197 Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global CRM197 Sales Value by Region (US$ Million), 2021–2026

Table 25. Global CRM197 Sales Value by Region (US$ Million), 2027–2032

Table 26. Global CRM197 Sales Value by Region (%), 2021–2026

Table 27. Global CRM197 Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions CRM197 Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions CRM197 Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions CRM197 Sales Value, (US$ Million), 2027–2032

Table 31. Pfizer Inc. Basic Information List

Table 32. Pfizer Inc. Description and Business Overview

Table 33. Pfizer Inc. CRM197 Products, Services, and Solutions

Table 34. Revenue (US$ Million) in CRM197 Business of Pfizer Inc. (2021–2026)

Table 35. Pfizer Inc. Recent Developments

Table 36. Ligand Pharmaceuticals Basic Information List

Table 37. Ligand Pharmaceuticals Description and Business Overview

Table 38. Ligand Pharmaceuticals CRM197 Products, Services, and Solutions

Table 39. Revenue (US$ Million) in CRM197 Business of Ligand Pharmaceuticals (2021–2026)

Table 40. Ligand Pharmaceuticals Recent Developments

Table 41. CanSino Biologic Basic Information List

Table 42. CanSino Biologic Description and Business Overview

Table 43. CanSino Biologic CRM197 Products, Services, and Solutions

Table 44. Revenue (US$ Million) in CRM197 Business of CanSino Biologic (2021–2026)

Table 45. CanSino Biologic Recent Developments

Table 46. Beijing Kexing Biology Product Basic Information List

Table 47. Beijing Kexing Biology Product Description and Business Overview

Table 48. Beijing Kexing Biology Product CRM197 Products, Services, and Solutions

Table 49. Revenue (US$ Million) in CRM197 Business of Beijing Kexing Biology Product (2021–2026)

Table 50. Beijing Kexing Biology Product Recent Developments

Table 51. Scarab Genomics Basic Information List

Table 52. Scarab Genomics Description and Business Overview

Table 53. Scarab Genomics CRM197 Products, Services, and Solutions

Table 54. Revenue (US$ Million) in CRM197 Business of Scarab Genomics (2021–2026)

Table 55. Scarab Genomics Recent Developments

Table 56. Xpress Biologics Basic Information List

Table 57. Xpress Biologics Description and Business Overview

Table 58. Xpress Biologics CRM197 Products, Services, and Solutions

Table 59. Revenue (US$ Million) in CRM197 Business of Xpress Biologics (2021–2026)

Table 60. Xpress Biologics Recent Developments

Table 61. Fina Biosolutions Basic Information List

Table 62. Fina Biosolutions Description and Business Overview

Table 63. Fina Biosolutions CRM197 Products, Services, and Solutions

Table 64. Revenue (US$ Million) in CRM197 Business of Fina Biosolutions (2021–2026)

Table 65. Fina Biosolutions Recent Developments

Table 66. Eubiologics Basic Information List

Table 67. Eubiologics Description and Business Overview

Table 68. Eubiologics CRM197 Products, Services, and Solutions

Table 69. Revenue (US$ Million) in CRM197 Business of Eubiologics (2021–2026)

Table 70. Eubiologics Recent Developments

Table 71. EirGenix Inc. Basic Information List

Table 72. EirGenix Inc. Description and Business Overview

Table 73. EirGenix Inc. CRM197 Products, Services, and Solutions

Table 74. Revenue (US$ Million) in CRM197 Business of EirGenix Inc. (2021–2026)

Table 75. EirGenix Inc. Recent Developments

Table 76. Revenue (US$ Million) in CRM197 Business of Company 40 (2021–2026)

Table 77. Company 40 Recent Developments

Table 78. Key Raw Materials Lists

Table 79. Key Suppliers of Raw Materials Lists

Table 80. CRM197 Downstream Customers

Table 81. CRM197 Distributors List

Table 82. Research Programs/Design for This Report

Table 83. Key Data Information from Secondary Sources

Table 84. Key Data Information from Primary Sources

List of Figures

Figure 1. CRM197 Product Picture

Figure 2. Global CRM197 Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global CRM197 Sales Value (US$ Million), 2021–2032

Figure 4. CRM197 Report Years Considered

Figure 5. Global CRM197 Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by CRM197 Revenue in 2025

Figure 7. CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Research Grade CRM197 Picture

Figure 9. cGMP Grade CRM197 Picture

Figure 10. Global CRM197 Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global CRM197 Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Pneumococcal Conjugate Vaccine

Figure 13. Product Picture of Meningococcal Polysaccharide Conjugate Vaccine

Figure 14. Product Picture of Others

Figure 15. Global CRM197 Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global CRM197 Sales Value Market Share by Application, 2025 & 2032

Figure 17. North America CRM197 Sales Value (US$ Million), 2021–2032

Figure 18. North America CRM197 Sales Value by Country (%), 2025 vs 2032

Figure 19. Europe CRM197 Sales Value (US$ Million), 2021–2032

Figure 20. Europe CRM197 Sales Value by Country (%), 2025 vs 2032

Figure 21. Asia Pacific CRM197 Sales Value (US$ Million), 2021–2032

Figure 22. Asia Pacific CRM197 Sales Value by Subregion (%), 2025 vs 2032

Figure 23. South America CRM197 Sales Value (US$ Million), 2021–2032

Figure 24. South America CRM197 Sales Value by Country (%), 2025 vs 2032

Figure 25. Middle East & Africa CRM197 Sales Value (US$ Million), 2021–2032

Figure 26. Middle East & Africa CRM197 Sales Value by Country (%), 2025 vs 2032

Figure 27. Key Countries/Regions CRM197 Sales Value (%), 2021–2032

Figure 28. United States CRM197 Sales Value (US$ Million), 2021–2032

Figure 29. United States CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 30. United States CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 31. Europe CRM197 Sales Value (US$ Million), 2021–2032

Figure 32. Europe CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 33. Europe CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 34. China CRM197 Sales Value (US$ Million), 2021–2032

Figure 35. China CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 36. China CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 37. Japan CRM197 Sales Value (US$ Million), 2021–2032

Figure 38. Japan CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 39. Japan CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 40. South Korea CRM197 Sales Value (US$ Million), 2021–2032

Figure 41. South Korea CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 42. South Korea CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 43. Southeast Asia CRM197 Sales Value (US$ Million), 2021–2032

Figure 44. Southeast Asia CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 45. Southeast Asia CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 46. India CRM197 Sales Value (US$ Million), 2021–2032

Figure 47. India CRM197 Sales Value by Type (%), 2025 vs 2032

Figure 48. India CRM197 Sales Value by Application (%), 2025 vs 2032

Figure 49. CRM197 Value Chain

Figure 50. CRM197 Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of CRM197 in 2032? zhanKai

The global market size of CRM197 in 2032 was 277 Million USD.

What is the annual compound growth rate of the global CRM197 market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of CRM197 in 2026? shouQi

Which companies rank high in the global CRM197 market? shouQi

Related Reports

Global CRM197 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CRM197 market size was US$ 194 million in 2025 and is forecast to reach a readjusted size of US$ 277 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
Global CRM197 Market Research Report 2026
The global CRM197 market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 277 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 110
USD 2900.00
(Single User License)
Global CRM197 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global CRM197 market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 77
USD 4250.00
(Single User License)
Global CRM197 Market Outlook, In‑Depth Analysis & Forecast to 2031
The global CRM197 market is projected to grow from US$ 185 million in 2024 to US$ 264 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 124
USD 4900.00
(Single User License)
CRM197- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for CRM197 was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 92
USD 3950.00
(Single User License)
Global CRM197 Market Research Report 2025
The global market for CRM197 was valued at US$ 185 million in the year 2024 and is projected to reach a revised size of US$ 264 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-07
Pages: 77
USD 2900.00
(Single User License)
CRM197 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published Date: 2024-01-18
Pages: 97
USD 3950.00
(Single User License)
Global CRM197 Market Research Report 2024
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published Date: 2024-01-03
Pages: 74
USD 2900.00
(Single User License)

Global CRM197 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CRM197 market size was US$ 194 million in 2025 and is forecast to reach a readjusted size of US$ 277 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
USD 4250.00 (Single User License)
Global CRM197 Market Research Report 2026
The global CRM197 market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 277 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 110
USD 2900.00 (Single User License)
Global CRM197 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global CRM197 market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 77
USD 4250.00 (Single User License)
Global CRM197 Market Outlook, In‑Depth Analysis & Forecast to 2031
The global CRM197 market is projected to grow from US$ 185 million in 2024 to US$ 264 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 124
USD 4900.00 (Single User License)
CRM197- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for CRM197 was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 92
USD 3950.00 (Single User License)
Global CRM197 Market Research Report 2025
The global market for CRM197 was valued at US$ 185 million in the year 2024 and is projected to reach a revised size of US$ 264 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-02-07
Pages: 77
USD 2900.00 (Single User License)
CRM197 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published: 2024-01-18
Pages: 97
USD 3950.00 (Single User License)
Global CRM197 Market Research Report 2024
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published: 2024-01-03
Pages: 74
USD 2900.00 (Single User License)